The transmission of critical medical information is stuck in the past. Due to an outdated and unnecessary rule, pharmacies and healthcare providers still receive prescription drug information on paper, which is wasteful, harmful to the environment, and nonsensical. Legislation to update this process and bring common sense to the dissemination of this critical information has […]
Price controls in any industry do not work and inevitably lead to shortages and disrupted markets. Price controls on biopharmaceuticals are especially harmful because they raise costs, stifle research and development of new cures and treatments, and threaten America’s position as the global industry leader. As the Inflation Reduction Act (IRA) was being considered by […]
The 340B Drug Discount Program started in 1992 with the laudable intention of helping federally funded hospitals that serve a large number of uninsured patients cover the costs of drugs and provide discounts to patients. However, due to the lack of a clear definition of an eligible patient and poor oversight, the program has drifted […]
Eliminating waste, fraud, and abuse continues to be a priority across the legislative and executive branches of the federal government. Lawmakers who are fighting against wasteful spending should agree to eliminate an outdated and unnecessary rule that would result in the modernization of how critical medical information is transmitted. It would both bring common sense […]
The Food and Drug Administration (FDA) announced draft guidance for premarket tobacco product applications (PMTAs) for electronic delivery systems (ENDS) that modifies the agency’s consideration of flavored products. The March 9, 2026, proposal states that a flavored ENDS product application must show that the benefits outweigh the risks to meet the standard of “appropriate for […]
On December 23, 2025, Sen. Rand Paul (R-Ky.) released his annual Festivus report, which cites a total of $1.6 trillion in unnecessary federal spending, including $1.22 trillion in interest payments on the national debt. The report cites $77 million for Department of Defense (DOD)’s outdated Marine Mammal Program, which trains dolphins and sea lions to […]
The enhanced Affordable Care Act subsidies that were at the center of the October government shutdown were not only made available to people making as much as $500,000 annually but also turned out to be rife with waste, fraud, and abuse. A December 3, 2025, Government Accountability Office (GAO) report revealed that the advanced premium […]
As Americans gather with family and friends to celebrate Thanksgiving, healthcare costs are one of their main concerns. President Trump has made lowering drug prices and increasing domestic biopharmaceutical research and development high priorities in his second term in office. Domestic investment by drug companies has skyrocketed since Eli Lilly was the first company to […]
The United States is the global leader in developing innovative and life-saving cures and treatments thanks to the investments made by pharmaceutical companies in the United States, including the vaccines that helped end the coronavirus pandemic. Vaccines are crucial to the physical and economic health of not just Americans but also people across the rest […]
Welcome to This Week in Waste, a series by Citizens Against Government Waste (CAGW) that highlights how taxpayer dollars are being wasted in the federal, state, and local levels of government and efforts to fight back against this spendthrift behavior. Senate Health, Education, Labor, and Pensions (HELP) Committee Hearing is Next Step for 340B Reform The […]
